Evercore Wealth Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $387K | Sell |
2,112
-30
| -1% | -$5.53K | 0.01% | 312 |
|
|
2025
Q4 | $377K | Hold |
2,142
| – | – | 0.01% | 320 |
|
|
2025
Q3 | $300K | Hold |
2,142
| – | – | ﹤0.01% | 350 |
|
|
2025
Q2 | $269K | Hold |
2,142
| – | – | ﹤0.01% | 350 |
|
|
2025
Q1 | $293K | Hold |
2,142
| – | – | ﹤0.01% | 344 |
|
|
2024
Q4 | $328K | Hold |
2,142
| – | – | ﹤0.01% | 330 |
|
|
2024
Q3 | $415K | Hold |
2,142
| – | – | 0.01% | 296 |
|
|
2024
Q2 | $497K | Hold |
2,142
| – | – | 0.01% | 278 |
|
|
2024
Q1 | $462K | Sell |
2,142
-8
| -0.4% | -$1.87K | 0.01% | 290 |
|
|
2023
Q4 | $556K | Sell |
2,150
-10
| -0.5% | -$2.46K | 0.01% | 269 |
|
|
2023
Q3 | $555K | Hold |
2,160
| – | – | 0.01% | 263 |
|
|
2023
Q2 | $615K | Sell |
2,160
-3
| -0.1% | -$893 | 0.01% | 252 |
|
|
2023
Q1 | $601K | Buy |
2,163
+13
| +0.6% | +$3.6K | 0.01% | 260 |
|
|
2022
Q4 | $595K | Sell |
2,150
-100
| -4% | -$28.2K | 0.01% | 257 |
|
|
2022
Q3 | $601K | Hold |
2,250
| – | – | 0.01% | 242 |
|
|
2022
Q2 | $459K | Hold |
2,250
| – | – | 0.01% | 265 |
|
|
2022
Q1 | $474K | Sell |
2,250
-26
| -1% | -$5.65K | 0.01% | 289 |
|
|
2021
Q4 | $546K | Sell |
2,276
-1,336
| -37% | -$344K | 0.01% | 272 |
|
|
2021
Q3 | $1.02M | Sell |
3,612
-998
| -22% | -$327K | 0.02% | 218 |
|
|
2021
Q2 | $1.6M | Sell |
4,610
-107
| -2% | -$32.4K | 0.03% | 187 |
|
|
2021
Q1 | $1.32M | Buy |
4,717
+29
| +0.6% | +$7.82K | 0.03% | 200 |
|
|
2020
Q4 | $1.15M | Sell |
4,688
-501
| -10% | -$129K | 0.02% | 198 |
|
|
2020
Q3 | $1.47M | Sell |
5,189
-118
| -2% | -$32.9K | 0.04% | 165 |
|
|
2020
Q2 | $1.42M | Sell |
5,307
-31
| -0.6% | -$9.32K | 0.04% | 166 |
|
|
2020
Q1 | $1.69M | Sell |
5,338
-285
| -5% | -$86.5K | 0.06% | 144 |
|
|
2019
Q4 | $1.67M | Sell |
5,623
-200
| -3% | -$55.5K | 0.04% | 169 |
|
|
2019
Q3 | $1.36M | Buy |
5,823
+112
| +2% | +$26.1K | 0.04% | 175 |
|
|
2019
Q2 | $1.34M | Sell |
5,711
-102
| -2% | -$23.6K | 0.04% | 174 |
|
|
2019
Q1 | $1.37M | Sell |
5,813
-299
| -5% | -$94.2K | 0.04% | 175 |
|
|
2018
Q4 | $1.84M | Buy |
6,112
+137
| +2% | +$43.7K | 0.07% | 136 |
|
|
2018
Q3 | $2.11M | Sell |
5,975
-471
| -7% | -$162K | 0.07% | 139 |
|
|
2018
Q2 | $1.87M | Buy |
6,446
+2,225
| +53% | +$626K | 0.06% | 147 |
|
|
2018
Q1 | $1.16M | Sell |
4,221
-150
| -3% | -$46.6K | 0.04% | 174 |
|
|
2017
Q4 | $1.39M | Sell |
4,371
-583
| -12% | -$187K | 0.05% | 166 |
|
|
2017
Q3 | $1.55M | Sell |
4,954
-172
| -3% | -$50.9K | 0.06% | 153 |
|
|
2017
Q2 | $1.39M | Sell |
5,126
-241
| -4% | -$63.7K | 0.05% | 162 |
|
|
2017
Q1 | $1.47M | Sell |
5,367
-44
| -0.8% | -$12.4K | 0.06% | 160 |
|
|
2016
Q4 | $1.53M | Buy |
5,411
+910
| +20% | +$270K | 0.06% | 149 |
|
|
2016
Q3 | $1.41M | Buy |
4,501
+28
| +0.6% | +$8.29K | 0.06% | 157 |
|
|
2016
Q2 | $1.08M | Buy |
4,473
+138
| +3% | +$36.4K | 0.05% | 167 |
|
|
2016
Q1 | $1.13M | Sell |
4,335
-43
| -1% | -$11.4K | 0.05% | 167 |
|
|
2015
Q4 | $1.34M | Sell |
4,378
-231
| -5% | -$66.4K | 0.06% | 159 |
|
|
2015
Q3 | $1.34M | Buy |
4,609
+24
| +0.5% | +$7.93K | 0.06% | 154 |
|
|
2015
Q2 | $1.85M | Sell |
4,585
-34
| -0.7% | -$13.6K | 0.08% | 144 |
|
|
2015
Q1 | $1.95M | Sell |
4,619
-426
| -8% | -$168K | 0.09% | 141 |
|
|
2014
Q4 | $1.71M | Buy |
5,045
+309
| +7% | +$100K | 0.09% | 133 |
|
|
2014
Q3 | $1.57M | Sell |
4,736
-152
| -3% | -$50.1K | 0.08% | 155 |
|
|
2014
Q2 | $1.54M | Buy |
4,888
+24
| +0.5% | +$7.22K | 0.08% | 152 |
|
|
2014
Q1 | $1.49M | Sell |
4,864
-135
| -3% | -$42.9K | 0.08% | 151 |
|
|
2013
Q4 | $1.4M | Sell |
4,999
-399
| -7% | -$103K | 0.08% | 163 |
|
|
2013
Q3 | $1.3M | Buy |
5,398
+208
| +4% | +$46.6K | 0.07% | 189 |
|
|
2013
Q2 | $1.12M | Buy |
+5,190
| New | +$1.11M | 0.06% | 197 |
|
Other funds holding BIIB
VCM
VPM
Evercore Wealth Management's BIIB Position: Q1 2026 in Review
Evercore Wealth Management reduced its Biogen (BIIB) stake by 1.4% in Q1 2026, selling an estimated $5.53K and leaving 2,112 shares worth $387K. The position accounts for 0.01% of the portfolio, ranked #312.
Evercore Wealth Management first reported a position in BIIB in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.11M in Q3 2018. 1,003 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Evercore Wealth Management held 2,112 shares of Biogen worth $387K as of Q1 2026.
- Evercore Wealth Management sold 30 Biogen shares in Q1 2026, an estimated $5.53K.
- Biogen made up 0.01% of Evercore Wealth Management's portfolio in Q1 2026, its #312 holding.
- Evercore Wealth Management first reported a position in Biogen in Q2 2013 and has held it in 52 quarters since.
- Evercore Wealth Management's Biogen position peaked at $2.11M in Q3 2018.
- 1,003 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Evercore Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.